Tirzepatide Powder: Appearance, Colour and Quality Tests

Lyophilized tirzepatide should be a white to off-white powder that dissolves to a clear, colourless solution. The U.S. prescribing information for the licensed product describes it as “clear, colorless to slightly yellow.” Anything outside that, such as strong colour, haze or particles, is a reason to verify the material before use. This article explains what to look for and how tirzepatide quality is tested.

For laboratory research use only. The compounds discussed are not approved for human or veterinary use and are not drugs, foods or cosmetics. This article summarises published research and is not medical advice.

Key points

Powder: white to off-white cake or loose powder.
Solution: clear, colourless; a faint yellow tint is within the licensed product description.
Identity: MS should match 4813.53 Da.
Purity (HPLC) and peptide content are different measurements.
Moisture and light are the main threats to the powder.

Appearance guide

Observation	Interpretation	Action
White, dry powder or cake	Normal	Proceed
Clear, colourless solution after reconstitution	Normal	Proceed
Faint yellow solution	Within licensed-product description; can also reflect concentration or light exposure	Note on label; check COA
Strong yellow, pink or red	Not expected for tirzepatide	Do not use; test identity and purity
Haze or strands that do not clear	Self-association of the lipidated peptide, or concentration too high	See reconstitution troubleshooting
Wet-looking or collapsed, sticky cake	Moisture ingress	Verify by HPLC before use

Identity: mass spectrometry

Tirzepatide’s formula is C₂₂₅H₃₄₈N₄₈O₆₈, with an average molecular weight of 4813.53 Da. In electrospray MS, a peptide of this size appears as a series of multiply charged ions. For example, [M+3H]³⁺ appears near m/z 1605, [M+4H]⁴⁺ near m/z 1204 and [M+5H]⁵⁺ near m/z 964. Deconvolution of these ions gives the intact mass. Common modifications are easy to spot:

Mass shift	Likely cause
+16 Da	Oxidation (e.g. tryptophan)
+1 Da (isotope-resolved)	Deamidation of Gln/Asn
+18 Da / fragment masses	Hydrolysis
+22, +38 Da	Sodium or potassium adducts (not degradation)

Analytical reviews of peptide chemical instability describe how these pathways are detected and distinguished (Reubsaet et al., 1998).

Purity and content

Reverse-phase HPLC with UV detection gives purity as the main-peak area percentage. It does not measure water or counter-ion. Synthetic peptides purified by HPLC are commonly isolated as trifluoroacetate salts, and exchanging the counter-ion requires specific procedures (Roux et al., 2008). So a vial with 99% HPLC purity can still contain noticeably less than its label weight as free peptide. Net peptide content, if reported, gives the actual amount.

COA item	What it tells you
HPLC purity (%)	Fraction of the main peak; degradation and synthesis impurities
MS (observed vs theoretical)	Identity
Net peptide content	Actual peptide per vial
Water content	Residual moisture
Appearance	White powder / clear solution

Each lot of our tirzepatide research peptide is supplied with HPLC and MS results.

Protecting the powder

Moisture: lyophilized proteins have an optimal residual moisture, and excess water accelerates degradation (Hsu et al., 1992). Keep vials sealed and warm them before opening.
Light: tryptophan and tyrosine residues are susceptible to photo-oxidation, even under visible light through sensitising impurities (Schöneich, 2020). Keep vials in their carton.
Temperature: −20 °C long-term; short ambient transit is generally tolerated.

More detail: lyophilized peptide storage and what lyophilized peptides contain.

After reconstitution

Reconstitute with gentle swirling, check clarity and colour, and refrigerate. The method and molar conversions are in how to reconstitute tirzepatide; use the peptide reconstitution calculator for concentrations.

Open questions for buyers of research peptides

Certificates of analysis for research-grade tirzepatide vary in depth. Many report HPLC purity and an MS identity check but not net peptide content, water content or the counter-ion. Because the C20 diacid side chain can also degrade or be incompletely attached during synthesis, a high HPLC purity should be accompanied by an MS result that matches the full lipidated mass, not only the peptide backbone. If an MS result shows a mass about 500–600 Da lower than expected, that may indicate a missing side chain. Ask the supplier to explain any discrepancy before using the material.

Related research

What is tirzepatide?
Retatrutide vs tirzepatide
How peptide purity is tested

Frequently asked questions

What color is tirzepatide?

Lyophilized tirzepatide is a white to off-white powder. In solution it is clear and colourless; the U.S. prescribing information for the licensed product describes it as clear, colourless to slightly yellow.

Why might tirzepatide solution look yellow or red?

A slight yellow tint is within the licensed product’s description. Strong yellow, pink or red colours are not expected and may indicate contamination, degradation or a labelling error; such material should not be used until tested.

How is tirzepatide identity confirmed?

By mass spectrometry. The expected average molecular weight is 4813.53 Da; electrospray MS shows multiply charged ions from which this mass is calculated.

What does HPLC purity mean for tirzepatide?

It is the proportion of the main peak among UV-absorbing components. It does not account for water or counter-ion, so it is not the same as peptide content.

Is tirzepatide powder hygroscopic?

Lyophilized peptides generally absorb moisture. Keep vials sealed, store cold, and let them warm to room temperature before opening.

References

DailyMed. Tirzepatide injection, solution — U.S. prescribing information. U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0
PubChem Compound Summary for CID 166567236, Tirzepatide. National Center for Biotechnology Information. https://pubchem.ncbi.nlm.nih.gov/compound/166567236
Reubsaet JL, et al. Analytical techniques used to study the degradation of proteins and peptides: chemical instability. J Pharm Biomed Anal. 1998. PMID: 9884187 https://pubmed.ncbi.nlm.nih.gov/9884187/
Hsu CC, et al. Determining the optimum residual moisture in lyophilized protein pharmaceuticals. Dev Biol Stand. 1992. PMID: 1592175 https://pubmed.ncbi.nlm.nih.gov/1592175/
Roux S, et al. Elimination and exchange of trifluoroacetate counter-ion from cationic peptides: a critical evaluation of different approaches. J Pept Sci. 2008. PMID: 18035848 https://pubmed.ncbi.nlm.nih.gov/18035848/
Schöneich C. Photo-Degradation of Therapeutic Proteins: Mechanistic Aspects. Pharm Res. 2020. PMID: 32016661 https://pubmed.ncbi.nlm.nih.gov/32016661/